Top Banner
PRINSIP KHEMOTERAPI Sub-Bagian Hematologi dan Onkologi Medik Bagian Ilmu Penyakit Dalam F.K Unand Padang
31

KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Jan 19, 2016

Download

Documents

ima_nekonayagi
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

PRINSIPKHEMOTERAPI

Sub-Bagian Hematologi dan Onkologi Medik

Bagian Ilmu Penyakit Dalam F.K Unand Padang

Page 2: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Pembedahan (Surgery) Penyinaran (Radioterapi) Pemberian Obat Anti-neoplasma (Khemoterapi) Kombinasi Surgery/Radioterapi/ Khemoterapi

Page 3: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Untuk Mencegah Sel Kanker - Multiplikasi : Memperbanyak Diri Pertumbuhan Tumor - Invasi : Merusak Sekitarnya - Metastase : Anak Sebar

Page 4: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

KHE

CAN

SEL NORMAL

FOLIKELRAMBUT

MUC.MEMB

SEL KANKER

SUMSUM TULANG

Page 5: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Fase G.O (Istarahat)

Fase. G.1 (Sintesa Protein & DNA) Fase. S (Sintesa DNA)

Fase. G.2 (Sintesa Protein & RNA)

Fase. M (Mitosis Sel)

Page 6: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Fase G.1 : - Asparginase - Prednison Fase S : - Cytarabine - Fluorouracil - Methotrexate - Fludarabine - hydroxyuria

Page 7: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Fase G.2 : - Bleomycine - Etoposide - Paclitaxel Fase M : - Vinblastine - Vincristine - Vindestine

Page 8: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Alkylating Agent : Antimetabolites Natural Product Hormon Dan Hormon Antagonis Miscellaneus Agent

Page 9: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Alkylating Agent : - Cyclophosphamide - Chlorambucil - Melphalan - Busulfan - Cisplatin Dan Carboplatin Antimetabolite : - Methotrexate - Cytarabine - Fluorouracil - Mercaptopurine

Page 10: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Natural Product : - Inhibisi Mitosis : Vincristine Dan Vinblastine - Antibiotika : Bleocine, Dounoru- Bicine Dan Doxorub - Enzim : Asparginase Hormon : - Prednison - Tamoxifen - Magestrol Asetat

Page 11: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Miscelaneous Agent : - Hydroxyurea - Procarbazine - Amsacrine

Page 12: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

DNA synthesis

AntimetabolitesAntimetabolites

DNA

DNA transcription DNA duplication

Mitosis

Alkylating agentsAlkylating agents

Spindle poisonsSpindle poisons

IIntercalating agentsntercalating agentsCellular levelCellular level

Action sites of cytotoxic agents Action sites of cytotoxic agents

Page 13: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

6-MERCAPTOPURINE

6-THIOGUANINE

METHOTREXATE

5-FLUOROURACIL

HYDROXYUREA

CYTARABINE

PURINE SYNTHESISPURINE SYNTHESIS PYRIMIDINE SYNTHESISPYRIMIDINE SYNTHESIS

RIBONUCLEOTIDESRIBONUCLEOTIDES

DEOXYRIBONUCLEOTIDESDEOXYRIBONUCLEOTIDES

DNADNA

RNARNA

PROTEINSPROTEINS

MICROTUBULESMICROTUBULESENZYMESENZYMES

L-ASPARAGINASE

VINCA ALKALOIDS

TAXOIDS

ALKYLATING AGENTS

ANTIBIOTICS

ETOPOSIDE

Action sites of cytotoxic agents Action sites of cytotoxic agents

Page 14: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Busulfan Cytosine Etoposide Bleomycin L-asparaginase

Carmustine Arabinoside Teniposide Dactinomycin Hydroxyurea

Chlorambucil Floxuridine Vinblastine Daunorubicin Procarbazine

Cisplatin Fluorouracil Vincristine Doxorubicin

Cyclophosphamide Mercaptopurine Vindesine Mitomycin-c

Ifosfamide Methotrexate Taxoids Mitoxantrone

Melphalan Plicamycin

AlkylatingAlkylating

AgentsAgentsAnti-Anti-

MetabolitesMetabolites

MitoticMitotic

InhibitorsInhibitors AntibioticsAntibiotics OthersOthers

Classification of cytotoxic agentsClassification of cytotoxic agents

Page 15: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Obat Anti-neoplasma : Efek Sel Kanker Sel Normal Pemilihan Obat Anti-neoplasma : - Maksimal Efek Thd Sel Kanker - Minimal Efek Thd Sel Normal (Efek Samping Minimal)

Page 16: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Cara Pemberian Obat : Tunggal Atau Kombinasi Dipilih Obat : - Potensial Utk Jenis Kanker tersebut - Dosis Tidak Meliwati Dosis Toksik - Kombinasi Obat Potensiasi 2 Fase Pertumbuhan sel

Page 17: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Treatment Pathway Diagnostic Workshop staging

Treatment

Primary Adjuvant NeoAdj Palliative

Page 18: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Dapat disembuhkan : - Koriokarsinoma - Lekemia Limfoblastik Akut - Limfoma Malignum Hodgkin - Limfoma Burkit - Tumor Wilm - Limfoma Limfoblastik - Sarkoma Ewing

Page 19: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Kanker Kandung Kemih Kanker Serviks Lekemia Mielositik Kronis Kanker Payu Dara Lekemia Limfositik Kronis Mieloma Multipel Kanker Ovarium Kanker Lambung Kanker Prostat

Page 20: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Sarkoma Osteogenik Kanker Pankreas Kanker Ginjal Kanker Tiroid Kanker Kolorektal Kanker Paru Melanoma Kanker Hepatoseluler

Page 21: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Akut : - Mual, Muntah Dan Diare - Reaksi Hipersensitifitas - Reaksi Lokal Kronik : - Depresi Sumsum tulang - Sistitis hemorrhagis - Alopesia - Kardio-nefro-hepatotoksik - Ganguan Sistem muko-kutan :

Stomatitis - Fibrosis paru - Neuropati

Page 22: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Mielosupresi : Anemi, Leukopeni Dan Trombositopeni Mual Dan Muntah Efek Muko-kutaneus : Mukostis, Alopesia, Rash Dan Gatal Sal Cerna : Anoreksia, Diare, Ganguan Fungsi hati (Ikterus)

Page 23: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Efek Kardiovaskuler : Aritmia, Hipotensi, Miokarditis, Edema paruEfek Neuro-psikiatris Neurits perifer, Mata kabur, Perubahan mentalEfek Sal Kencing : Gangguan fungsi ginjal,asidosisLain-lain : Demam, Mialgia, Artralgia, lesu

Page 24: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

Mucositis

Nausea/vomiting

Diarrhea

Cystitis

Sterility

Myalgia

Neuropathy

Alopecia

Pulmonary fibrosis

Cardiotoxicity

Local reaction

Renal failure

Myelosuppression

Phlebitis

Side effects of chemotherapySide effects of chemotherapy

Page 25: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

1. Diagnosis penyakit harus pasti (patologi anatomi)

2. Penentuan stadium harus tepat3. Pemilihan protokol obat yang diberikan :

tunggal atau kombinasi4. Penentuan dosis dan cara pemberian

obat5. Melihat KU pasien : indeks Karnovsky

Page 26: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

6. Keadaan hematologi7. Keadaan fungsi ginjal, hati dan jantung8. Kemampuan penderita dalam penyediaan obat9. Keyakinan akan kepatuhan penderita10. Penerangan terhadap efek dan efek samping obat

Page 27: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt

1. Remisi komplit : semua keluhan, gejala dan kel laboratorium hilang

2. Remisi parsial : terjadi pengurangan 50% atau lebih

3. Tidak ada respon : pengurangan kurang dari 50%

4. Progresif : tumor bertambah

Page 28: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt
Page 29: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt
Page 30: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt
Page 31: KULIAH PRINSIP KHEMOTERAPI 30 sept 13.ppt